EU Commission to end AstraZeneca and J&J vaccine contracts at expiry – paper

0
149
imageStock Markets10 hours ago (Apr 14, 2021 07:20)

2/2
© Reuters. FILE PHOTO: Oxford/AstraZeneca’s COVID-19 vaccine at a vaccination centre in Antwerp

2/2

MILAN (Reuters) – The EU Commission has decided not to renew COVID-19 vaccine contracts next year with companies such as Astrazeneca (LON:AZN) and Johnson & Johnson (NYSE:JNJ) (J&J), Italian daily La Stampa reported on Wednesday citing a source from the Italian Health Ministry.

“The European Commission, in agreement with the leaders of many (EU) countries, has decided that the contracts with the companies that produce (viral vector) vaccines that are valid for the current year will not be renewed at their expiry,” the newspaper reported.

It added that Brussels would rather focus on COVID-19 vaccines using messenger RNA (mRNA) technology, such as Pfizer (NYSE:PFE)’s and Moderna (NASDAQ:MRNA)’s.

The European Commission is seeking clarification from J&J about the company’s “completely unexpected” announcement of delays in COVID-19 vaccine deliveries to the EU, an EU official told Reuters on Tuesday.

EU Commission to end AstraZeneca and J&J vaccine contracts at expiry – paper

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

LEAVE A REPLY

Please enter your comment!
Please enter your name here